top of page
GC Therapeutics, Inc.
A Path to SuperCells™ Therapies
Our Technology
GCTx uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cell fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
Home: Our Technology
Home: About Us
Our Team
George Church, Ph.D.
Senior Advisor
Co-founder
Parastoo Khoshakhlagh, Ph.D.
Chief Executive Officer,
Co-founder
Alex Ng, Ph.D.
Chief Scientific Officer,
Co-founder
Home: Our Team
Home: Our Team
Kiavash Kiaee
Stem Cell Biologist
Mark Zaki
Medical Analyst
Khaled Said
Molecular Biologist
Home: Join Us
Home: Quote
Press Release
"Engineering cell types is the key to cell therapies, transplants and testing new drugs"
George Church
Evan Appleton, Ph.D.
Machine Learning Fellow
Home: News
Home: Contact
bottom of page